APRE vs KDP · $10.4M cap vs P/E 23, rev $15.35B
Aprea Therapeutics Inc (APRE) versus Keurig Dr Pepper Inc (KDP) — a side-by-side from cached financials, not a winner call.
Aprea Therapeutics Inc (APRE) is a biotechnology company listed on US.
Keurig Dr Pepper Inc (KDP) is a beverages - non-alcoholic company listed on NASDAQ.
APRE does not have a complete income-statement cache yet.
Latest reported KDP revenue for 2024-12-31 was $15.35B. Net income was $1.44B. Revenue was up 3.6% from 2023-12-31 to 2024-12-31. KDP currently screens at market cap $42.03B and trailing P/E 22.9.
APRE currently screens at market cap $10.4M. KDP currently screens at market cap $42.03B and trailing P/E 22.9.
Not investment advice. Open the APRE and KDP stock pages for the full models.
Not investment advice.